FATE THERAPEUTICS INC's ticker is and the CUSIP is 31189P952. A total of 3 filers reported holding FATE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $70 | -48.5% | 14,900 | -37.7% | 0.00% | – |
Q1 2023 | $136 | +257.9% | 23,900 | +528.9% | 0.00% | – |
Q4 2022 | $38 | -100.0% | 3,800 | -35.6% | 0.00% | – |
Q3 2022 | $132,000 | +100.0% | 5,900 | +118.5% | 0.00% | – |
Q2 2022 | $66,000 | -65.1% | 2,700 | -44.9% | 0.00% | – |
Q1 2022 | $189,000 | -19.2% | 4,900 | +22.5% | 0.00% | – |
Q4 2021 | $234,000 | +212.0% | 4,000 | +400.0% | 0.00% | – |
Q3 2021 | $75,000 | +8.7% | 800 | 0.0% | 0.00% | – |
Q2 2021 | $69,000 | -43.9% | 800 | +5233.3% | 0.00% | – |
Q1 2021 | $123,000 | +173.3% | 15 | +200.0% | 0.00% | – |
Q4 2020 | $45,000 | -23.7% | 5 | -66.7% | 0.00% | – |
Q3 2020 | $59,000 | -64.0% | 15 | -68.8% | 0.00% | – |
Q2 2020 | $164,000 | -86.5% | 48 | -91.2% | 0.00% | -100.0% |
Q1 2020 | $1,212,000 | -40.9% | 546 | -47.9% | 0.00% | -50.0% |
Q4 2019 | $2,050,000 | +78.7% | 1,048 | +41.8% | 0.00% | +33.3% |
Q3 2019 | $1,147,000 | -62.6% | 739 | -51.1% | 0.00% | -62.5% |
Q2 2019 | $3,069,000 | +14.2% | 1,512 | -1.2% | 0.01% | +14.3% |
Q1 2019 | $2,688,000 | +447.5% | 1,530 | +299.5% | 0.01% | +600.0% |
Q4 2018 | $491,000 | -55.1% | 383 | -42.9% | 0.00% | -75.0% |
Q3 2018 | $1,093,000 | +78.6% | 671 | +24.3% | 0.00% | +100.0% |
Q2 2018 | $612,000 | +620.0% | 540 | +32.0% | 0.00% | -50.0% |
Q1 2018 | $85,000 | +962.5% | 409 | +718.0% | 0.00% | – |
Q4 2017 | $8,000 | +700.0% | 50 | +900.0% | 0.00% | – |
Q3 2017 | $1,000 | – | 5 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 26,200 | $336,000 | 0.00% |
SIMPLEX TRADING, LLC | 383 | $491,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |